| Literature DB >> 28239282 |
Paulina Frączek1, Aneta Kilian-Kita1, Mirosława Püsküllüoglu1, Krzysztof Krzemieniecki1.
Abstract
The mystery of Traditional Chinese Medicine has been attracting people for years. Acupuncture, ranked among the most common services of Complementary and Alternative Medicine, has recently gained a lot of interest in the scientific world. Contemporary researchers have been continuously trying to shed light on its possible mechanism of action in human organism. Numerous studies pertaining to acupuncture's application in cancer symptoms or treatment-related side effects management have already been published. Moreover, since the modern idea of acupuncture's immunomodulating effect seems to be promising, scientists have propounded a concept of its potential application as part of direct anti-tumor therapy. In our previous study we summarized possible use of acupuncture in management of cancer symptoms and treatment-related ailments, such as chemotherapy-induced nausea and vomiting, pain, xerostomia, vasomotor symptoms, neutropenia, fatigue, anxiety, insomnia, lymphoedema after mastectomy and peripheral neuropathy. This article reviews the studies concerning acupuncture as a possible tool in modern anticancer treatment.Entities:
Keywords: acupuncture; anticancer treatment; cancer; complementary treatment; therapy
Year: 2017 PMID: 28239282 PMCID: PMC5320457 DOI: 10.5114/wo.2016.65604
Source DB: PubMed Journal: Contemp Oncol (Pozn) ISSN: 1428-2526
Fig. 1Hypothetical model explaining how acupuncture stimulates the immune system (based on [11])
Summary of possible immunomodulating effects of acupuncture
| Possible immunomodulating effects of acupuncture | Results | Ref. |
|---|---|---|
| NK cell activation | – direct antitumor activity through both secretory and non-secretory mechanism of killing cancer cells | [ |
| – bone marrow stem cells stimulation | [ | |
| Increased IL-2 level | – NK cells stimulation | [ |
| NO synthesis | – NK cells activation | [ |
| Increased endogenous B-endorphin | IFN-γ synthesis | [ |
| Increased IFN-γ level | Mediates NK cell activity: | [ |
NKp44: NK-cell surface receptor, one of the major receptors responsible for triggering NK cell cytotoxic activity [26]
NK cell – natural killer cell; DC – dendritic cell; SPI1 – Spi-1 proto-oncogene; IL – interleukin; NO – nitrogen oxide; IFN-γ – interferon γ; TNF – tumor necrosis factor
Examples of studies concerning acupuncture’s immunomodulating effects
| Study type | Results | Ref. |
|---|---|---|
| Animal model | Mice with transplanted mammary cancer | [ |
| Animal model | – increased NK activity ( | [ |
| Animal model | – significantly enhanced NK cell splenic cytotoxity ( | [ |
| Case series | 60 patients with metastatic colorectal cancer | [ |
| Case series | 17 healthy volunteers | [ |
| Lack of data | 45 patients with malignant tumors (20 controls) | [ |
| RCT (phase II) | 51 patients with malignant neoplasm, 48 healthy controls | [ |
| Lack of data | 40 patients with malignant tumors (20 controls), acupunctured group exhibited: | [ |
NK – natural killer; IFN-γ – interferon γ; IL-2 – interleukin 2; RCT – randomized controlled trial; CD – cluster of differentiation
Studies concerning acupuncture as anticancer treatment.
| Study type | Results | Ref. |
|---|---|---|
| Case series | patients with superficial tumors underwent electroacupuncture: | [ |
| Case series | 106 patients with liver cancer | [ |
| Case series | Omura’s ST36 point stimulation: | [ |
| Case report | 52-year-old woman with DCIS | [ |
| Animal model | Mice with transplanted mammary cancer | [ |
| Animal model | Liver cancer, gastric cancer and hypodermic tumor rat models were obtained by implantation of replicated Walker-256 cell strain. | [ |
| Animal model | Mice with implanted osteosarcoma – stimulation of ST36 acupoint: | [ |
| Animal model | Mice with inoculated Lewis lung carcinoma | [ |
| Systematic review and meta-analysis | – enhancement of immediate tumor response | [ |
CR – complete remission; PR – partial remission; ORR – overall response rate; DCIS – ductal carcinoma in situ